ProShare Advisors LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1357955 BETHESDA, MD

Position in DYN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$517,115

+$33,353 QoQ

Shares Held

23,283

-12.7% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#142

of 245 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. DYN ranks #52 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$517,115	23,283	-12.7%	Shares	Sole	2026-08-11
2026-03-31	$483,762	26,683	-7.8%	Shares	Sole	2026-04-27
2025-12-31	$565,792	28,926	+21.8%	Shares	Sole	2026-02-06
2025-09-30	$300,323	23,741	+1.1%	Shares	Sole	2025-11-06
2025-06-30	$223,624	23,490	+1.3%	Shares	Sole	2025-08-07
2025-03-31	$242,630	23,196	-17.3%	Shares	Sole	2025-05-08
2024-12-31	$660,716	28,044	+32.4%	Shares	Sole	2025-02-14
2024-09-30	$760,857	21,182	+39.6%	Shares	Sole	2024-11-14
2024-06-30	$535,349	15,170	-7.0%	Shares	Sole	2024-08-13
2024-03-31	$462,955	16,307	+44.6%	Shares	Sole	2024-05-08
2023-12-31	$150,010	11,279	+2.9%	Shares	Sole	2024-02-14
2022-03-31	$105,712	10,966	-20.6%	Shares	Sole	2022-05-10
2021-12-31	$164,307	13,819	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.